These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 911352)

  • 1. Experimental radiation synovectomy by 165Dy ferric hydroxide macroaggregate.
    Sledge CB; Noble J; Hnatowich DJ; Kramer R; Shortkroff S
    Arthritis Rheum; 1977; 20(7):1334-42. PubMed ID: 911352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysprosium (165Dy) hydroxide macroaggregates for radiation synovectomy--animal studies.
    McLaren A; Hetherington E; Maddalena D; Snowdon G
    Eur J Nucl Med; 1990; 16(8-10):627-32. PubMed ID: 2384101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of antigen-induced arthritis in rabbits with dysprosium-165-ferric hydroxide macroaggregates.
    Zuckerman JD; Sledge CB; Shortkroff S; Venkatesan P
    J Orthop Res; 1989; 7(1):50-60. PubMed ID: 2908912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation synovectomy with 165Dy-FHMA: lymph node uptake and radiation dosimetry calculations.
    Zalutsky MR; Venkatesan PP; English RJ; Shortkroff S; Sledge CB; Adelstein SJ
    Int J Nucl Med Biol; 1986; 12(6):457-65. PubMed ID: 3710708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental radiation synovectomy in rabbit knee with holmium-166 ferric hydroxide macroaggregate.
    Mäkelä O; Penttilä P; Kolehmainen E; Sukura A; Sankari S; Tulamo RM
    Nucl Med Biol; 2002 Jul; 29(5):593-8. PubMed ID: 12088730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysprosium-165 ferric hydroxide macroaggregates for radiation synovectomy.
    Hnatowich DJ; Kramer RI; Sledge CB; Noble J; Shortkroff S
    J Nucl Med; 1978 Mar; 19(3):303-8. PubMed ID: 632909
    [No Abstract]   [Full Text] [Related]  

  • 7. Synovectomy of the rheumatoid knee using intra-articular injection of dysprosium-165-ferric hydroxide macroaggregates.
    Sledge CB; Zuckerman JD; Shortkroff S; Zalutsky MR; Venkatesan P; Snyder MA; Barrett WP
    J Bone Joint Surg Am; 1987 Sep; 69(7):970-5. PubMed ID: 3654709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiosynovectomy with dysprosium-165 iron hydroxide].
    Pirich C; Wanivenhaus A; Graninger W; Kvaternik H; Angelberger P; Pesau B; Havlik E; Flores J; Sinzinger H
    Acta Med Austriaca; 1993; 20(1-2):49-53. PubMed ID: 8475681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis.
    Pirich C; Pilger A; Schwameis E; Germadnik D; Prüfert U; Havlik E; Lang S; Kvaternik H; Flores JA; Angelberger P; Wanivenhaus A; Rüdiger HW; Sinzinger H
    J Nucl Med; 2000 Feb; 41(2):250-6. PubMed ID: 10688107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of beta dosimetry in radiation synovectomy using Monte Carlo simulation (EGS4).
    Johnson LS; Yanch JC
    Med Phys; 1993; 20(3):747-54. PubMed ID: 8350831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis using radiopharmaceuticals.
    Zuckerman JD; Sledge CB; Shortkroff S; Venkatesan P
    Int J Rad Appl Instrum B; 1987; 14(3):211-8. PubMed ID: 3667304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy?
    Chinol M; Vallabhajosula S; Zuckerman JD; Goldsmith SJ
    Int J Rad Appl Instrum B; 1990; 17(5):479-86. PubMed ID: 2391243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhenium-188 sulphur colloid as a radiation synovectomy agent.
    Wang SJ; Lin WY; Hsieh BT; Shen LH; Tsai ZT; Ting G; Knapp FF
    Eur J Nucl Med; 1995 Jun; 22(6):505-7. PubMed ID: 7556293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the NIH. Radionuclide therapy for arthritic knees.
    Doepel LK
    JAMA; 1985 Feb; 253(6):744-5. PubMed ID: 3968805
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counter.
    Pirich C; Prüfert U; Havlik E; Schwarmeis E; Flores J; Kvaternik H; Angelberger P; Aiginger J; Wanivenhaus A; Sinzinger H
    Eur J Nucl Med; 1997 Apr; 24(4):398-402. PubMed ID: 9096090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection.
    Vella M; Zuckerman JD; Shortkroff S; Venkatesan P; Sledge CB
    Arthritis Rheum; 1988 Jun; 31(6):789-92. PubMed ID: 3382451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular radiation synovectomy.
    Sledge CB; Atcher RW; Shortkroff S; Anderson RJ; Bloomer WD; Hurson BJ
    Clin Orthop Relat Res; 1984; (182):37-40. PubMed ID: 6319062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of lapine cartilage matrix after radiosynovectomy with holmium-166 ferric hydroxide macroaggregate.
    Mäkelä OT; Lammi MJ; Uusitalo H; Hyttinen MM; Vuorio E; Helminen HJ; Tulamo RM
    Ann Rheum Dis; 2003 Jan; 62(1):43-9. PubMed ID: 12480668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-articular radiation treatment of rheumatoid synovitis of the ankle with dysprosium-165 ferric hydroxide macroaggregates.
    Barnes CL; Shortkroff S; Wilson M; Sledge CB
    Foot Ankle Int; 1994 Jun; 15(6):306-10. PubMed ID: 8075761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorbed dose profiles for radionuclides of frequent use in radiation synovectomy.
    Johnson LS; Yanch JC
    Arthritis Rheum; 1991 Dec; 34(12):1521-30. PubMed ID: 1747137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.